Inpatient chemotherapy clinical pathway for head and neck cancer

Taku Yamashita, Seiichi Shinden, Naoki Oishi, Hideyuki Saito

Research output: Contribution to journalArticlepeer-review


Recently, a clinical pathway has been rapidly introduced to many medical fields, but not sufficiently for the treatment of head and neck cancer because patients show different pathology and disease courses. If the process of diagnosis and treatment is segmentalized into small steps and a clinical pathway for each step is created, clinical pathways will be also more easily introduced to diseases with diversity, such as head and neck cancer. This study shows an example of our clinical pathway with segmentalized treatment procedures, a clinical pathway for inpatient chemotherapy. It is suggested that the introduction of a clinical pathway for chemotherapy is useful for improved operational efficiency and informed consent, enhanced risk management, and the practice of team medicine.

Original languageEnglish
Pages (from-to)587-592
Number of pages6
JournalToukeibu Gan
Issue number4
Publication statusPublished - 2005
Externally publishedYes


  • chemotherapy
  • clinical pathway
  • head and neck cancer
  • risk management

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Oncology


Dive into the research topics of 'Inpatient chemotherapy clinical pathway for head and neck cancer'. Together they form a unique fingerprint.

Cite this